Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (792)	12/18/1998 7:29:00 PM
From: nigel bates	Read Replies (1) \| Respond to of 3202

>>OK everyone, what drove INCY today???<< Could it just be recognition of value ? .....surely not. PKN has been pretty strong too of late. Maybe it's just the c.elegans genome publicity. nig

To: Rocketman who wrote (792)	12/22/1998 7:59:00 AM
From: Dub Brown	Read Replies (1) \| Respond to of 3202

Two analysts on CNBC cited INCY as there favorite pick

To: Rocketman who wrote (792)	12/24/1998 4:10:00 PM
From: Larry Liebman	Respond to of 3202

Rocketman, I am interested in your take on HGSI. I have been tempted recently. The patent arsenal, the vaccine work with companies like MEDI, the clinical trials, etc., all point to some significant implied value IMHO. When I watch ONSL rocket, I have to wonder at what time the market will recognize the full value of INCY and HGSI- or the even more fallen angels of GENE, MYGN, or AXPH. Now, what would happen if HGSI and INCY "merged" their patent kingdomes? Anyway, I'd appreciate your opinion of HGSI.